Anzeige
Mehr »
Dienstag, 22.07.2025 - Börsentäglich über 12.000 News
Alarm am Metallmarkt: Kupfer unter Strom: USA rüsten sich - was das für Anleger bedeutet
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PZ7S | ISIN: FR0013481835 | Ticker-Symbol: 7V91
Frankfurt
21.07.25 | 21:48
0,170 Euro
-2,07 % -0,004
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
KLEA HOLDING Chart 1 Jahr
5-Tage-Chart
KLEA HOLDING 5-Tage-Chart
RealtimeGeldBriefZeit
0,1870,19221.07.
Actusnews Wire
186 Leser
Artikel bewerten:
(1)

KLEA HOLDING: Klea Holding accelerates its growth in the first half of 2025

  • Number of tests performed up by +55% compared with +24% in 2024;
  • Sales up +48% at constant exchange rates;
  • Confirmation of development and performance plan.

Paris, 21 July 2025

KLEA HOLDING (FR0013481835 - ALKLH), a group specialising in the acquisition, development and digitalisation of companies in various sectors, presents its unaudited sales figures for the first half of 2025.

Acceleration in the volume of tests carried out


Number of tests performed (in volume)H1 2024H1 2025Var. 25/24
Medical Fitness tests68,515105,342+54%
Health & Wellness tests1,6983,712+119%
Total number of tests performed70,213109,054+55 %

The volume of tests carried out in the 3 Smart Salem medical centres in Dubai increased by +55% between the first half of 2024 and the first half of 2025. This performance confirms the continued growth in Medical Fitness tests (+54%) and the rise in Health Check tests (+119%).

This remarkable performance comes on the back of +24% annual growth in 2024 and +31% growth in the first quarter of 2025.

Strong sales growth despite unfavourable currency impact

At 30 June - €m - unaudited financialsH1 2024[1]H1 2025[2]Var. 25/24
published
Var. 25/24 cst. rate
Medical Fitness segment7.510.3+37%+39%
Health & Wellness tests and other segments0.40.9+139%+142%
Other revenues[3]0.00.3--
Klea Holding consolidated sales7.911.5+46%+48%

On the back of this increase in the number of tests, half-year sales reached €11.5m, up +46% on a reported basis, taking into account the unfavourable impact of exchange rates. At constant exchange rates, sales growth was +48%.

Smart Salem is also benefiting from the first revenues from the new services developed since 2024, in particular around occupational health tests.

Confirmation of objectives

Klea Holding confirms the elements of its roadmap unveiled at the last Annual General Meeting of Shareholders, at which Raphael Smila, a director and the largest shareholder controlling more than 20% of the company's capital, was appointed Chairman and CEO.

This plan is based on the following elements:

  1. Drastic cost reductions at Klea Holding and its subsidiaries.
  2. EBITDA 2025 expected to improve significantly.
  3. Continued and accelerated deleveraging of the Group.

The Group also confirms its intention to develop its activities in Dubai (Smart Salem) and Saudi Arabia (Smart Health).

An update on these various projects will be provided as they progress, and at the latest when the half-year results are published.

About Klea Holding

Klea Holding is a group focused on acquiring, developing and digitizing companies in various sectors to maximize their growth and value. Through its "scaling industries of the future" identity, Klea Holding draws on its successful experience in developing Smart Salem, the first network of digitalized medical analysis centers accredited by the Dubai Ministry of Health (DHA) in the United Arab Emirates, and its Smart Health joint venture developed in Saudi Arabia, to extend this entrepreneurial approach to the four corners of the globe.

Klea Holding is headquartered in Paris and listed on Euronext Growth (ALKLH). For further information, please visit http://www.kleaholding.com.

Investor Relation: Jérôme FABREGUETTES LEIB // +33 1 53 67 36 78 // kleaholding@actus.fr

Press Relation: Fatou-Kiné N'DIAYE // +33 1 53 67 36 34 // fndiaye@actus.fr


[1] Average exchange rate H1 2024: EUR/AED = 3.9726

[2] Average exchange rate H1 2025: EUR/AED = 4.0178

[3] Occupational health tests, pre-employment tests, service charges, etc.

------------------------
This publication embed "Actusnews SECURITY MASTER".
- SECURITY MASTER Key: ynCdZ5SYZm+WyHBsYsdlmWRmZpljmpGYbGOWyZdwlZeacGmUmGppZ5vIZnJklmdo
- Check this key: https://www.security-master-key.com.
------------------------
Full and original release in PDF format:
https://www.actusnews.com/documents_communiques/ACTUS-0-93122-alklh_cp_ca_s1_2025_eng.pdf

© Copyright Actusnews Wire
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free
© 2025 Actusnews Wire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.